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Abstract 
Long bone non-union continues to be a significant worldwide problem. Since its inception over a decade ago, the 
‘diamond concept’, a conceptual framework of what is essential for a successful bone healing response, has gained 
great acceptance for assessing and planning the management of fracture non-unions. Herein, we discuss the epide-
miology of non-unions, the basic science of bone healing in the context of the diamond concept, the currently avail-
able results and areas for future research.
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Introduction
Since its inception, the diamond concept has proven 
itself to be an important framework for understanding 
the minimal requirements for fracture healing. Moreover, 
it has shown itself to be particularly useful when plan-
ning surgical management of fracture non-union of both 
upper and lower extremities [1–13].
Non-union has been defined in various ways, with a 
55% disagreement amongst clinicians on timing [14]. 
The US Federal Drug Administration council defines it 
as ‘failure to achieve union by 9 months since the injury, 
and for which there has been no signs of healing for 
3 months’. Others, however, have recommended that for 
long bones this should be revised to a period of 6 months 
if no evidence of radiological fracture healing is present 
[15]. Instability at the fracture site in true non-union is 
often associated with ongoing pain, and as such, clinical 
signs are as important in diagnosis as the radiological 
examination [14, 16].
Well-vascularised fracture sites with abundant fracture 
haematoma but an unstable mechanical environment 
will usually develop ‘hypertrophic’ non-union, whereas 
impaired blood supply in combination with local strain 
concentration has been suggested to lead to ‘atrophic’ 
non-union [17]. These definitions are based on the radio-
graphic appearance of non-union [17]. The presence or 
absence of infection is also important in terms of classi-
fication, which can further complicate the clinical picture 
and treatment modality [18].
Incidence of non-union has been variably reported in 
the literature, depending on study size, patient demo-
graphics, injury location and severity and method of 
treatment, from anywhere between 2 and 30% [19] with 
an estimated 100,000 episodes of fracture non-union 
per year in the USA [16]. A recent study from Australia 
on 853 patients showed overall 8% of patients who had 
fractures, being admitted to hospital per year for frac-
ture healing complications [20]. However, a recent much 
larger population-based study done in Scotland showed 
lower overall incidence than previously reported, at 1.9% 
in the adult population, with incidence of non-union for 
pelvis and femur fractures of 13 per 1000, humerus of 30 
per 1000 and tibia of 55 per 1000; incidence was seen to 
peak in the 25–44-year age group [21]. This comes with 
significant financial implications, with reported overall 
costs between £21,183 and £33,752 per patient [22, 23].
Risk of non‑union
Risks of non-union can be defined as patient dependent 
and independent, as well as local and systemic, some of 
which can be modified to enhance fracture healing.
A recent systematic review into risk stratification 
showed that quality of evidence quantifying relative 
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risks is variable, ranging from level 1 to level 5 evidence. 
Table 1 illustrates a summary of existing risk factors [16, 
24–26].
Attempts have been made to develop scoring systems 
to predict the risk of early non-union, including the Non-
Union Scoring System (NUSS) [27] and the Moghaddam 
risk score [28]. Some authors have suggested that the 
appropriate treatment modality of non-union should be 
based on the severity of the non-union scoring system 
used.
Fracture healing and the diamond concept
A successful fracture healing response is dependent on 
the biological environment at the fracture site (availabil-
ity of molecular mediators, progenitor cells and matrix, 
immunoregulatory cells amongst others) and an opti-
mum mechanical environment that provides the fracture 
site with adequate stability, facilitating the evolution of a 
physiological process leading to a successful bone repair 
response. In general terms, there are two mechanisms 
by which bone can heal, which are influenced by the 
local mechanical fracture environment. Direct, or pri-
mary cortical bone healing occurs where there is ‘abso-
lute stability’ of bony surfaces with close contact of less 
than 0.15  mm, and minimal inter-fragmentary strains 
of less than 2%; this can only be achieved by compres-
sion lag screw or compression plating [16, 29–31]. The 
second mechanism is by indirect, or secondary bone 
healing which is facilitated by relative stability. Over-
all, the phases of fracture repair are broadly divided into 
fracture haematoma formation, inflammation, cellular 
proliferation and differentiation, and remodelling [32, 
33].
The ‘diamond concept’, being a conceptual framework 
for a successful bone repair response, gives equal impor-
tance to mechanical stability and the biological envi-
ronment. Moreover, adequate bone vascularity and the 
physiological state of the host are thought to be essential 
within this framework of fracture repair. A deficit in the 
biological environment or the mechanical environment, 
or failure to appreciate the comorbidities of the host and 
the lack of vascularity can all lead to an impaired fracture 
healing response (non-union). Overall, the diamond con-
cept refers to the availability of osteoinductive mediators, 
osteogenic cells, an osteoconductive matrix (scaffold), 
optimum mechanical environment, adequate vascular-
ity, and addressing any existing comorbidities of the host 
(Fig. 1) [1, 2]. The important constituents of the diamond 
concept are discussed in more detail below.
Osteoinductive mediators
Initial bleeding following fracture initiates the coagula-
tion cascade; this leads to development of a fracture hae-
matoma [34]. This contains platelets and macrophages, 
which release a series of cytokines (cell signalling mol-
ecules) of different types, stimulating a cascade of events 
to initiate healing. These include proinflammatory 
interleukins 1, 6, 8, 10 and 12, tumour necrosis factor-a 
(TNFa), activated protein C (APC), monocyte chemoat-
tractive protein (MCP), macrophage colony-stimulat-
ing factor (M-CSF), receptor activator of nuclear factor 
kappa B ligand (RANKL) and osteoprogenin (OPG) [1, 
Table 1 Risk factors for non-union
a Potentially modifiable, bInconclusive—under research
Patient dependent Patient independent
Modifiable Non‑modifiable
Smoking Age Open reduction (poor quality of primary ORIF)a
Alcohol Male gender Open fracture (more bone loss and soft tissue injury)
Nutritional deficiency (including vitamin D) Genetic  predispositionb Wedge and multi-fragmentary fracture pattern
High BMI Diabetes (metabolic disease) Initial displacement
Peripheral vascular disease Compartment  syndromea
Osteoporosis Affected bone: highest in tibia
Chronic inflammatory disease Fracture site in relation to vascularisation zone
Renal insufficiency Presence of fracture gap post-surgerya
Insulina Poor mechanical stability by initial  implanta
Opiatesa Infectiona
NSAIDsa
Steroidsa
Antibioticsa
Anticoagulantsa
Chemotherapeuticsa
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34, 35]. Metalloproteinases and angiogenic factors such 
as vascular endothelial growth factor (VEGF) also play 
an important role in the overall bone repair process [1, 
34, 35]. However, the most important mediators released 
having a direct effect on progenitor cells to undergo the 
process of mitogenesis and osteoblastic differentiation 
include platelet-derived growth factor (PDGF), fibroblast 
growth factor (FGF), insulin-like growth factor (IGF) and 
transforming growth factor beta (TGFβ) proteins, which 
include bone morphogenic protein (BMP)-2, 4, 6 and 7 
(Fig. 2) [1, 34, 35].
Osteogenic cells
Osteogenic cells, which comprise both committed osteo-
progenitor cells from the periosteum as well as undif-
ferentiated multipotent stem cells (MSCs) from bone 
marrow and endothelial progenitor cells, are also acti-
vated according to the local fracture environment in the 
haematoma [1]. The cytokine release leads to an ensu-
ing inflammatory phase, characterised by increased 
blood flow and vascular permeability, and chemotaxis 
with activation of the complement cascade. Osteoclasts 
and fibroblasts initiate conversion of haematoma into 
granulation tissue, laying down a fibrin meshwork which 
is then invaded by a new capillary network allowing fur-
ther MSC migration. Following activation, cytokines are 
also released by endothelial cells, MSCs, chondrocytes, 
osteocytes and osteoblasts themselves [1, 15, 34, 36]. 
This is followed by the proliferation and differentiation 
of MSCs, leading to simultaneous hard and soft callus 
formation, which is highly influenced by the mechani-
cal micro-environment and fracture biology [29, 32, 37]. 
Higher oxygen tension at periosteal surfaces distal to the 
fracture site, as well as other factors, encourages prefer-
ential MSC differentiation into osteoblasts [16]. In the 
peripheral (cortical) zone, osteocalcin initiates periosteal 
osteoblasts to produce type 1 collagen, leading to intram-
embranous ossification (hard callus). In central (medul-
lary) zones, MSCs develop into chondrocytes, initially 
laying down type 2 collagen (soft callus) known as endo-
chondral ossification; by week  3, increasing osteocalcin 
induces calcification and hard callus formation here too 
(Fig. 3). Mineralisation of fracture callus into an osteoid-
type matrix and type 1 collagen fibrils leads to bridging of 
the fracture site and disordered ‘woven bone’ formation 
[31, 38–41]. Critical in guiding this process are the BMPs, 
which are responsible for inducing osteogenic activity in 
mesenchymal stem cells and maturation of lamellar bone, 
as well as helping coordinate osteoclastic activity [32, 42–
44]. Inhibitory and fibrinolytic molecules also play a key 
role in regulating the process, without which bone heal-
ing has shown to be delayed [32, 35, 45]. This is followed 
by a period of remodelling by bone multicellular units 
(BMUs) in a process of activation, resorption, reversal 
Fig. 1 Illustration of the ‘diamond concept’ of bone healing
Fig. 2 Diagrammatic representation of fracture haematoma 
composition. Key: IL interleukin, MCP monocyte chemoattractive 
protein, M-CSF monocyte colony-stimulating factor, BMP bone 
morphogenic protein, PDGF platelet-derived growth factor, VEGF 
vascular endothelial growth factor, RANKL receptor activator of 
nuclear factor kappa-B ligand, OPG osteoprotegerin, SOST sclerostin 
(Adapted from Walters et al. [34] used with permission)
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and formation, taking at least 6 months to complete. The 
disordered woven bone, which is comparatively weak, 
develops into stronger, organised lamellar bone follow-
ing in general the principles of Wolff’s law, who showed 
that the trabecular pattern of bone corresponds to the 
mechanical stresses placed upon it [46–48].
Extracellular osteoconductive matrix (scaffold)
An osteoconductive extracellular matrix, acting as a 
scaffold and promoting migration and adhesion of oste-
oinductive and osteogenic cells to the fracture site, is 
essential for fracture healing. Where there is good appo-
sition of bone, necrotic bone at the fracture site serves 
this purpose. If there is insufficient ‘natural’ scaffold, then 
autograft, or allograft demineralised bone matrix (DBM), 
which also has inherent osteoinductive capability thanks 
to retained growth factors including BMP, can be used 
when treating non-union of bone defects [1, 32, 42, 43, 
49, 50].
Mechanical environment
Evidence suggests that cells are able to sense the sur-
rounding mechanical environment, through elec-
trochemical signals generated by fluid shift within 
canaliculae (osteocytes), and also other cell types have 
cell membrane mechanoreceptors and direct connec-
tions between the cell nucleus and local cytoskeleton, 
which are further influenced by the chemical environ-
ment and cellular signalling molecules [37]. Based on 
studies of cells in culture, cellular development has been 
shown to be greatly influenced by local mechanics, with 
the mechanical and physiological environment impact-
ing significantly upon subsequent lineage differentiation 
of multi-potent mesenchymal stem cells. In the pres-
ence of appropriate growth factors, tension encourages 
fibroblasts, shear encourages chondroblasts, and a com-
bination of compression/distraction encourages osteo-
blasts—reflecting the mechanical environment in which 
the cells usually develop [29].
Strain, defined as extension per unit length in relation 
to the force applied, reflecting loading and micromotion 
at the fracture site, is important to initiate healing, as dis-
cussed by Perren [17, 30]. Axial micromotion seems to 
stimulate fracture healing in the early stages; by 8 weeks, 
this relationship reverses, being reflected in normal 
healing by increasing callus stiffness, which naturally 
aims to decrease movement at this stage [29, 30]. Low 
strain rates promote intramembranous ossification, but 
Fig. 3 Diagrammatic representation of ossification: a Intramembranous ossification. Osteoinductive mediators induce osteogenic MSCs to 
differentiate into osteoblasts, which lay down osteoid (collagen-1 rich); this mineralises to form an ossification centre, whence mineralisation 
extends. There is terminal differentiation into osteocytes, becoming entombed in the bone matrix. b Endochondral ossification. Osteoinductive 
mediators induce osteogenic MSCs to differentiate into chondrocytes; a cartilage matrix is secreted which forms the template for endochondral 
bone formation. Chondrocytes then undergo hypertrophic differentiation and mineralise the surrounding matrix. They eventually undergo 
apoptosis—resulting in vascular invasion. Invading blood vessels convey osteoblasts which form bone on the cartilage template [46]
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endochondral ossification is more likely to be initiated 
if the strain rate is increased. When strain is increased 
too far, however, increased differentiation down the soft 
tissue lineage pathway predominates, leading to delayed 
or non-union [31]. For ossification to occur, the fracture 
gap must have reduced to an appropriate level, impacted 
in turn by the relative stiffness of the tissues around it. 
Experiments have shown that this should be ideally less 
than 2 mm and certainly less than 6 mm, above which lit-
tle callus is seen to form [31, 38].
Vascularity and host factors
If vascular supply or fracture haematoma is compromised 
or lost, there is a higher risk of non-union, as insufficient 
osteoinductive and osteogenic cells will be available at 
the fracture site to initiate osteogenesis, remodelling and 
healing [2, 45]. The chance of this significantly increases 
in high-energy and open fractures, or in primary surgi-
cal repair where the fracture biology, periosteum and soft 
tissue envelope are not respected [24, 51]. Periosteum, as 
well as providing critical blood supply, also has unique 
regenerative potential [52, 53]. Similarly, if there is altered 
systemic host (patient) physiology or comorbidities, this 
will also impact healing potential [2, 24, 45, 51, 52].
Biological chamber
The concept of the biological chamber is based on the 
need for containment; For instance, where a long bone 
non-union case has been managed with the diamond 
principle, one has to appreciate that any biological 
enhancement that was placed at the site of non-union 
must be contained locally so that the maximum effect 
will be exerted. It is the development of a chamber which 
allows an influx of biological activities to promote a heal-
ing response in a timely fashion. In a sense, what we are 
referring to is the development of a ‘bioreactor’. Con-
finement of the treatment selected for non-union can 
be achieved with modification of soft tissues, biological 
membranes, sealants etc. This is especially important 
when one considers the relative mean retention times of 
these ingredients [2, 54].
Methods
Search criteria: Ovid SP was used to search Embase 
Classic and Embase databases, as well as Ovid Medline. 
Search term under ‘all headings’: ‘diamond concept’. 
Papers which were not original and not discussing long 
bones, not using human subjects, not in the English lan-
guage and review articles and letters were excluded from 
the study; one poor-quality case report was excluded 
from the study also. However, review articles were down-
loaded and used for reference purposes.
Each paper was systematically searched for: area of 
treatment, level of evidence, study size (n), objectives, 
study type, patient characteristics, methods, non-union 
risk profile, assessment of union, length of follow-up, 
time to union, and outcomes: radiological and clini-
cal union, complications, microbiology results, and any 
risk factors which correlated with non-union, and docu-
mented in tabulated form, allowing straightforward ref-
erence for discussion.
Results
Overall, we found ten studies which met our inclusion 
criteria, including five retrospective cohort or case–
control studies [4, 6, 9, 12, 13], three prospective cohort 
studies [10, 11, 55] and two case reports [7, 8]. One 
study was excluded (case report by Dilogo et  al. 2017), 
as it was unclear whether this patient had achieved con-
firmed union at the time of reporting. The total number 
of patients included in these studies was 548. Overall 
success in treating non-union, when rigorously apply-
ing all aspects of the diamond concept, was 89–100%. 
When fewer of the principles and augmented elements 
of the ‘diamond’ were applied and depending on fracture 
type and location, overall success ranged from 44 to 90% 
(Table 2).
Discussion
The search for the best approach to treat long bone non-
union is ongoing. Particularly recalcitrant ones are more 
difficult to manage, with long-lasting treatment and high 
cost implications. The diamond concept approach offers 
a new paradigm for their management. In addition to 
correcting the mechanical environment, a potent biologi-
cal stimulus is provided locally by addition of a scaffold, 
growth factors and multipotent stem cells whilst respect-
ing the local blood supply and fracture biology. Moreo-
ver, patient-related comorbidities must be addressed to 
overcome inherent limitations of the host physiological 
processes.
In regard to upper limb studies, Calori et  al. [9] per-
formed a study on 54 patients with upper limb non-
union, comparing polytherapy ‘diamond concept’ versus 
monotherapy for non-unions. Patients treated with poly-
therapy [BMP-7, MSCs, synthetic or autologous bone 
graft (ABG), re-osteosynthesis] had worse cases of non-
union to begin with. Statistical analysis demonstrated 
superiority of polytherapy over monotherapy in clinical, 
radiological and functional outcomes, and a higher per-
centage (89 versus 63%) went onto union. Despite limita-
tions of fracture diversity, sample size and retrospective 
nature of the study, these results are compelling. Miska 
et al. [12] looked at 50 patients with humeral non-union, 
managed depending on their risk profile with various 
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aspects of the diamond concept, with only 6 patients hav-
ing the full spectrum of the diamond addressed. These 
were treated using angular stable plating (mechanical 
stability), autologous bone graft (MSCs and scaffold) and 
BMP-7 application (osteoinductive agent). Overall union 
rates of 80% were seen, however it is not clear how out-
comes in the ‘diamond concept’ group faired in compari-
son with the others.
Haubruck et al. [6] treated 156 patients with lower limb 
non-unions (69 femurs and 87 tibias), comparing BMP-2 
with BMP-7 for single- and two-stage revisions, using 
ABG to provide a scaffold and MSCs, and performed re-
osteosynthesis to enhance stability. Overall union rates 
were 91% with BMP-2 and 58% for BMP-7 (p < 0.001), 
with similar rates of overall healing between femur and 
tibia when BMP groups were combined, at 64 and 63%, 
respectively, but in the BMP-2 group these were 79% and 
97%, respectively, illustrating a good potential of the dia-
mond concept.
Giannoudis et  al. [4] published a retrospective cohort 
study of 14 patients with subtrochanteric femoral non-
unions, including four open fractures. Excellent outcome 
was achieved using all four principles in the diamond 
concept: debridement, blade plate or revision IM nail 
(mechanical stability), RIA (reamer/irrigator/aspirator) 
from the contralateral femur for ABG to use primarily 
as a scaffold, BMP-7 and bone marrow aspirate concen-
trate (BMAC) to provide MSCs from the iliac crest, with 
watertight closure in layers to ensure containment of bio-
active material in the ‘biological chamber’. Overall union 
rate was 90%. This study also highlighted the presence of 
varus mal-alignment of fixed acute fractures, emphasis-
ing that failure of mechanical stability was successfully 
corrected as part of ‘diamond concept’-focused manage-
ment. Goff [8] also reported an excellent outcome when 
applying all aspects of the diamond concept in treating 
delayed femoral intertrochanteric non-union, by using 
a two-stage modified Masquelet technique augmented 
with BMP-7 and RIA used to supply ABG. Giannoudis 
et al. [55] performed a further study, looking at fracture 
non-union from all sites (upper and lower limb). Apply-
ing the diamond concept to treat 64 patients of whom 
65% suffered high-energy injuries, they obtained a union 
rate of 98% by 12 months, again showing the potency of 
the diamond concept.
Moghaddam et al. [10] in a study of 88 patients with 
subtrochanteric femoral non-unions, including 21% 
with open fractures, applied all elements of the dia-
mond concept in patients deemed to be in a high-risk 
group for healing as part of a single- or two-stage pro-
cedure: RIA samples from the femur or ABG from the 
iliac crest used as a source of MSCs as well as a scaffold 
material, and some also supplemented with BMP-7 and 
tricalcium phosphate. Seventy-two patients received 
full ‘diamond concept’ augmentation, 13 cases only had 
ABG, and 3 only had revision of metalwork. No com-
plete ‘diamond concept’ group-specific outcome data 
are provided. Overall, 69 patients (78%) achieved good 
healing when applying this methodology, with union in 
single-stage procedures higher (95.1%) compared with 
two-stage (63.8%) overall. Rates of union were signifi-
cantly higher in the femoral diaphysis compared with 
distal femur (84 versus 70%, respectively), especially 
when managed using an intramedullary nail. Larger 
defects (5–10  cm) in the diaphysis managed with a 
two-stage procedure had poor healing rates (58%), 
with smoking having a significant impact. Only in cases 
where the defect did not cross the entire diameter and 
an osseous bridge was still present did healing occur. 
This study demonstrates that poor vascularity and diffi-
culty in achieving mechanical stability lead to impaired 
fracture healing, illustrating their importance for inclu-
sion in the diamond.
Moghaddam et al. [11] also investigated the treatment 
of tibial non-unions, with successful union of 84% in sin-
gle-stage (group 1) and 80% in two-stage (group 2) pro-
cedures, augmenting elements of the diamond concept 
according to risk profile, with 76.8% of patients overall 
receiving a combination of RIA, BMP-7 and tricalcium 
phosphate, in addition to re-osteosynthesis. Again, no 
‘complete diamond’ group-specific data are provided. 
Results show that applying ideas of the diamond concept 
based on risk profile when treating both fracture types 
led to acceptable union rates. Despite having worse ini-
tial starting position, patients in G2 had similar outcome 
afterwards. Authors suggest that a higher number of 
previous surgeries in G2 patients (mean 3.4 versus 2.4) 
contributed to worse healing due to scar tissue imped-
ing blood flow, however provide no absolute values or 
multivariate analysis with p values to substantiate the 
outcomes of this subgroup. G1 and G2 groups both fell 
into the ‘medium’ risk category for non-union on the 
Moghaddam prediction score, as well as the NUSS, and 
behaved as would have been expected; also patients in G2 
who had higher overall scores took longer to heal. Micro-
biology results suggest that, in previously undetected 
atrophic non-unions, low-grade infection may be the 
cause, and that in these cases, the Masquelet technique 
can be used effectively. Results also suggest that antibi-
otic osteitis prophylaxis was beneficial in the G1 group 
treated with gentamicin-coated nails.
Douras [7] presented a case study in which the full dia-
mond constituents were applied for a medial malleolus 
non-union, and achieved full union by 6  months, with 
the patient back to normal function, showing that the 
technique is also effective in ankle fracture non-union.
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Olivier [13] performed a study on 20 patients with 
recalcitrant tibial non-union, which aimed to apply 
the diamond concept principles in a different way. As 
well as debridement and re-osteosynthesis, a compos-
ite graft using synthetic resorbable calcium phosphate 
bone substitute combined with BMP was used instead 
of ABG, which may be useful in patients with poor 
bone stock. It is worth noting, however, that no aug-
mentation using stem cells was used. Union rates were 
90%, suggesting that it could be a safe and effective 
alternative where ABG is not possible.
The studies discussed here represent all of the litera-
ture which specifically refers to using the ‘diamond con-
cept’ as a principle in guiding management decisions 
in long bone non-union. As one can see, where all of 
the diamond concept principles are clearly adhered to 
and elements of this augmented during surgery, there 
are excellent rates of union after treatment for upper 
and lower limbs non-unions. Biological and mechani-
cal environment, systemic factors and local blood sup-
ply as well as fracture pattern, location and frequency 
of previous intervention and stability of implants used 
all could predict outcome. However, only a few of the 
above studies use bone marrow aspirate concentrate 
(BMAC) as a direct means of concentrating mesenchy-
mal stem cells to act as osteoprogenitors, with most 
relying on the MSCs present in RIA or autologous bone 
grafting from the iliac crest. In our experience, we have 
found that the RIA process washes most of the MSCs 
out of the bone stock, reducing its utility as a source 
of potent osteogenic cells. As we have previously pub-
lished, after the age of 55, even the iliac crest becomes 
less useful as a source of MSCs with a more ‘yellow’ 
appearance and fewer stem cells to aid union [56]. We 
believe that, in compromised cases, the use of BMAC 
to supply a reliable source of MSCs as part of the dia-
mond can help to achieve good results.
The evidence available to show that using ‘polyther-
apy’ with the diamond concept is preferable over ‘mon-
otherapy’ is convincing, but numbers are still small, as 
also discussed by Calori et  al. [57]. Some of the stud-
ies presented have only augmented all aspects of the 
diamond concept for high-risk patients, which may be 
obscuring the picture. Further studies in the future, 
of prospective randomised nature, would throw more 
light on this matter.
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